The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry
Open accessAbstract
Heparan sulfate proteoglycansGlycosaminoglycan chains on cell surface proteoglycans provide initial docking sites for the binding to eukaryotic cells of various viruses and other microorganisms.The ubiquitously expressed glycosaminoglycan heparan sulfate is particularly important in this regard, at least for viruses.Often, binding of a viral protein to heparan sulfate is only the first step in a cascade of interactions between virus and cell that is required for viral entry into the cell and the initiation of infection.The steps that occur after binding of virus to heparan sulfate may require the interaction of other viral proteins with other cell surface molecules.Several of the human herpesviruses, the focus of this Perspective, can make their initial contact with cells by binding to cell surface heparan sulfate.One member of this group, herpes simplex virus type 1 (HSV-1), can also bind to specific sites in heparan sulfate to trigger the fusion between viral envelope and cell membrane that is required for viral entry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Herpes Simplex Virus-1 Entry into Cells Mediated by a Novel Member of the TNF/NGF Receptor Family
Montgomery, R. I., Warner, M. S., Lum, B. J., & Spear, P. G. (1996) · Cell · doi:10.1016/s0092-8674(00)81363-x · Cited by 1,100
Self-citationA Novel Role for 3-O-Sulfated Heparan Sulfate in Herpes Simplex Virus 1 Entry
Shukla, D., Liu, J., Blaiklock, P., Shworak, N. W., Bai, X., Esko, J. D., Cohen, G. H., Eisenberg, R. J., Rosenberg, R. D., & Spear, P. G. (1999) · Cell · doi:10.1016/s0092-8674(00)80058-6 · Cited by 1,054
Self-citationInitial interaction of herpes simplex virus with cells is binding to heparan sulfate
WuDunn, D., & Spear, P. G. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.52-58.1989 · Cited by 919
Self-citationGeraghty, R. J., Krummenacher, C., Cohen, G. H., Eisenberg, R. J., & Spear, P. G. (1998) · Science · doi:10.1126/science.280.5369.1618 · Cited by 909
Self-citationRegulated Diversity of Heparan Sulfate
Lindahl, U., Kusche-Gullberg, M., & Kjellén, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.24979 · Cited by 678
Herold, B. C., WuDunn, D., Soltys, N., & Spear, P. G. (1991) · Journal of Virology · doi:10.1128/jvi.65.3.1090-1098.1991 · Cited by 572
Self-citationCell surface receptors for herpes simplex virus are heparan sulfate proteoglycans.
Shieh, M. T., WuDunn, D., Montgomery, R. I., Esko, J. D., & Spear, P. G. (1992) · The Journal of cell biology · doi:10.1083/jcb.116.5.1273 · Cited by 545
Self-citationCD46 Is a Cellular Receptor for Human Herpesvirus 6
Santoro, F., Kennedy, P. E., Locatelli, G., Malnati, M. S., Berger, E. A., & Lusso, P. (1999) · Cell · doi:10.1016/s0092-8674(00)81678-5 · Cited by 522
Three Classes of Cell Surface Receptors for Alphaherpesvirus Entry
Spear, P. G., Eisenberg, R. J., & Cohen, G. H. (2000) · Virology · doi:10.1006/viro.2000.0529 · Cited by 516
Self-citationWarner, M. S., Geraghty, R. J., Martinez, W. M., Montgomery, R. I., Whitbeck, J. C., Xu, R., Eisenberg, R. J., Cohen, G. H., & Spear, P. G. (1998) · Virology · doi:10.1006/viro.1998.9218 · Cited by 494
Self-citation
Research works printed but not linked: 10
- 10.1007/BF01310482 · doi:10.1007/bf01310482
- 10.1006/viro.1995.9957 · doi:10.1006/viro.1995.9957
- 10.1099/0022-1317-75-11-3087 · doi:10.1099/0022-1317-75-11-3087
- 10.1016/S0168-1702(97)00149-4 · doi:10.1016/s0168-1702(97)00149-4
- 10.1099/0022-1317-75-11-3081 · doi:10.1099/0022-1317-75-11-3081
- 10.1128/JVI.74.10.4530-4540.2000 · doi:10.1128/jvi.74.10.4530-4540.2000
- 10.1002/1096-9071(200012)62:4<487::AID-JMV14>3.0.CO;2-I · doi:10.1002/1096-9071(200012)62:4<487::aid-jmv14>3.0.co;2-i
- 10.1006/viro.2000.0624 · doi:10.1006/viro.2000.0624
- 10.1099/0022-1317-75-4-743 · doi:10.1099/0022-1317-75-4-743
- 10.1111/1523-1747.ep12499867 · doi:10.1111/1523-1747.ep12499867
Cited by
Order Out of Chaos: Assembly of Ligand Binding Sites in Heparan Sulfate
Esko, J. D., & Selleck, S. B. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135458 · Cited by 1,495
The Structure of Glycosaminoglycans and their Interactions with Proteins
Gandhi, N. S., & Mancera, R. L. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00741.x · Cited by 1,034
Silver Nanoparticles as Potential Antiviral Agents
Galdiero, S., Falanga, A., Vitiello, M., Cantisani, M., Marra, V., & Galdiero, M. (2011) · Molecules · doi:10.3390/molecules16108894 · Cited by 963
Christianson, H. C., Svensson, K. J., van Kuppevelt, T. H., Li, J.-P., & Belting, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304266110 · Cited by 903
Virus entry by macropinocytosis
Mercer, J., & Helenius, A. (2009) · Nature Cell Biology · doi:10.1038/ncb0509-510 · Cited by 816
The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications
McFadyen, J. D., Stevens, H., & Peter, K. (2020) · Circulation Research · doi:10.1161/circresaha.120.317447 · Cited by 592
Spear, P. G., & Longnecker, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10179-10185.2003 · Cited by 590
Self-citationCellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate
Barth, H., Schäfer, C., Adah, M. I., Zhang, F., Linhardt, R. J., Toyoda, H., Kinoshita-Toyoda, A., Toida, T., van Kuppevelt, T. H., Depla, E., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302267200 · Cited by 500
Exploitation of glycosylation in enveloped virus pathobiology
Watanabe, Y., Bowden, T. A., Wilson, I. A., & Crispin, M. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.05.012 · Cited by 482
Fusing structure and function: a structural view of the herpesvirus entry machinery
Connolly, S. A., Jackson, J. O., Jardetzky, T. S., & Longnecker, R. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2548 · Cited by 477
The versatile heparin in COVID-19
Thachil, J. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14821 · Cited by 404
Antiviral properties of lactoferrin--a natural immunity molecule
Berlutti, F., Pantanella, F., Natalizi, T., Frioni, A., Paesano, R., Polimeni, A., & Valenti, P. (2011) · Molecules · doi:10.3390/molecules16086992 · Cited by 356
Nicola, A. V., McEvoy, A. M., & Straus, S. E. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5324-5332.2003 · Cited by 352
Nanotechnology-based antiviral therapeutics
Chakravarty, M., & Vora, A. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00818-0 · Cited by 334
Ryckman, B. J., Jarvis, M. A., Drummond, D. D., Nelson, J. A., & Johnson, D. C. (2006) · Journal of Virology · doi:10.1128/jvi.80.2.710-722.2006 · Cited by 330
Antonio Chiocca, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc948 · Cited by 306
Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry
Akhtar, J., & Shukla, D. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07402.x · Cited by 292
Self-citationArterial and venous thromboembolism in COVID-19: a study-level meta-analysis
Tan, B. K., Mainbourg, S., Friggeri, A., Bertoletti, L., Douplat, M., Dargaud, Y., Grange, C., Lobbes, H., Provencher, S., & Lega, J.-C. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-215383 · Cited by 290
Different Heparan Sulfate Proteoglycans Serve asCellular Receptors for HumanPapillomaviruses
Shafti-Keramat, S., Handisurya, A., Kriehuber, E., Meneguzzi, G., Slupetzky, K., & Kirnbauer, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.24.13125-13135.2003 · Cited by 279
Viral effects on the content and function of extracellular vesicles
Raab-Traub, N., & Dittmer, D. P. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.60 · Cited by 269
Extracellular Vesicles Exploit Viral Entry Routes for Cargo Delivery
van Dongen, H. M., Masoumi, N., Witwer, K. W., & Pegtel, D. M. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00063-15 · Cited by 265
Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research
Koelle, D. M., & Corey, L. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.96-113.2003 · Cited by 263
Zheng, K., Xiang, Y., Wang, X., Wang, Q., Zhong, M., Wang, S., Wang, X., Fan, J., Kitazato, K., & Wang, Y. (2014) · mBio · doi:10.1128/mbio.00958-13 · Cited by 118
Tanaka, A., Tumkosit, U., Nakamura, S., Motooka, D., Kishishita, N., Priengprom, T., Sa-ngasang, A., Kinoshita, T., Takeda, N., & Maeda, Y. (2017) · Journal of Virology · doi:10.1128/jvi.00432-17 · Cited by 108
Snow, A. D., Cummings, J. A., & Lake, T. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.710683 · Cited by 84
Entry of equid herpesvirus 1 into CD172a+ monocytic cells.
Laval, K., Favoreel, H. W., Van Cleemput, J., Poelaert, K. C. K., Brown, I. K., Verhasselt, B., & Nauwynck, H. J. (2016) · Journal of General Virology · doi:10.1099/jgv.0.000375 · Cited by 12
Anti-herpes simplex virus type-1 activity of Eleusine indica methanol extract
Iberahim, R., Ahamad Bahtiar, A., & Ibrahim, N. (2016) · Malaysian Journal of Microbiology · doi:10.21161/mjm.s01116 · Cited by 6
de Oliveira, A. P., & Fraefel, C. (2010) · The Open Virology Journal · doi:10.2174/1874357901004030109 · Cited by 3
Metadata
- Authors
- Shukla, D., & Spear, P. G.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-08-15
- Volume
- 108
- Issue
- 4
- Pages
- 503-510
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2152170709
- Cited by
- 567
- References
- 41
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.